No significant differences were identified between the HFD-BC and HFD groups for all the following parameters: glucose tolerance (IPGTT), fasting blood glucose levels, fasting plasma insulin concentrations, the white adipocytes area in eWAT, and NAFLD activity score (Supplemental Figures S2–S4). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.